Covid-19 situation

The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
This statement reflects our perspective and the possible impact on our ability to supply as of March 16, 2020. TSS is closely monitoring developments around the novel coronavirus outbreak and we will continue to update you on the situation as it pertains to our business.
At present we have no supply disruption and the company operates without any impact on daily business. We have material in stock to continue to maintain delivery reliability.

Niclas Ohlsson, CEO TSS

We are taking the situation seriously and are focusing our efforts in minimizing the risk on future impact on business operations. We take several actions to support the national and international efforts to even out the spread over time and protect risk groups in the community.  Our contingency plans and activities are centered around the following areas:

Cross-functional response team

  • The management team meet daily to assess the situation and take measures as deemed necessary based on the latest published information.
  • We follow the guidelines of leading global and local governmental, health and work environment authorities.

Protecting employees

  • We currently have no employees known to be affected by the virus.
  • Employees who can perform their work duties from home are encouraged to do so.
  • Meetings are primarily held as video conference, travel is restricted.
  • New safety measurements by anyone receiving goods from external sources.
  • TSS premises have been equipped with additional disinfectant supplies and routines for use, in addition to daily extra cleaning and disinfection.

Supply chain integrity

  • TSS is operating with a structured Supply Chain Risk Management process and are prepared to manage emergency situations as best as possible.
  • We are closely monitoring our supplier’s abilities to supply components for our production. We currently have no delays or component shortage.
  • We demand and review contingency plans from our critical suppliers.
  • We have currently no disruption in delivering to planned destinations.

Stay close to customers

  • We more often than ordinary ask for a forecast update from customer. This is simply to ensure that we will be able to support any fluctuation in supply needs and ensure business continuity.

Financial stability

  • TSS is financially stable, and we currently don’t foresee any major disruption to our business due to the COVID-19 outbreak.

Finally, we are humble to the fact that we are currently part of one of the most important functions in the world. Securing the supply chain of pharmaceuticals, vaccines and other medical supplies and ensuring its integrity is of highest importance in situations like the one we are in now.

Stay safe!

You may also be interested in

A digital graphic of a networked globe, representing the theme of a webinar on global integrations in clinical trial management.

On-demand webinar: Maximize value with 2-way integrations in Clinical Trial Management

Watch this webinar in collaboration with endpoint Clinical to learn about using 2-way technology integrations to maximize value in clinical trial management.
Read moreDownload Whitepaper
A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read moreDownload Whitepaper

Meet Nina Nilsson, Chief Revenue Officer at TSS

We are delighted to officially welcome Nina Nilsson, our new Chief Revenue Officer. Nina is delivering great value to our customers by addressing key pain points, offering insight and understanding which can help to improve our customers business process.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.